This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher
When a biotech stock heads to the moon after releasing data on one of its drug programs, sometimes the party is just getting started.
And that might be exactly the case for Annovis Bio(NYSEMKT:ANVS), a biotech that’s trying to tackle Alzheimer’s disease…
